Home > Journals > Minerva Medica > Past Issues > Minerva Medica 2019 October;110(5) > Minerva Medica 2019 October;110(5):450-4

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe PROMO
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

REVIEW   

Minerva Medica 2019 October;110(5):450-4

DOI: 10.23736/S0026-4806.19.06095-6

Copyright © 2019 EDIZIONI MINERVA MEDICA

language: English

The clinical presentation in adulthood of juvenile idiopathic arthritis

Marta PRIORA , Simone PARISI, Maria C. DITTO, Richard BORRELLI, Clara L. PERONI, Angela LAGANÀ, Enrico FUSARO

Division of Rheumatology, A.O.U. “Città della Salute e della Scienza”, Turin, Italy



Juvenile idiopathic arthritis (JIA) is a chronic systemic inflammatory disease, which affects children and adolescents, characterized by significant differences when compared to inflammatory rheumatisms in adulthood. Today, in a panorama enriched in the last decades with great improvements in the diagnostic and therapeutic field, a far from negligible portion and an increasing number of patients with JIA require the continuation of treatments in adulthood. This specific population of patients, given the high incidence of extra-articular manifestations, residual irreversible disabilities, comorbidities related to an inflammatory process and extended immunosuppressive treatments during the age of development, requires precise attentions in the follow-up and a multidisciplinary approach characterized by different clinical, psychological and social aspects.


KEY WORDS: Arthritis, juvenile; Treatment outcome; Adult

top of page